Levothyroxine Dosing Recommendations
For young healthy adults with overt hypothyroidism, start with full replacement dosing at 1.6 mcg/kg/day based on ideal body weight, while patients over 50-60 years should begin with 50 mcg daily, and those with subclinical hypothyroidism require only 25-75 mcg daily depending on TSH elevation. 1, 2
Initial Dosing by Patient Population
Young Healthy Adults (Overt Hypothyroidism)
- Start with full replacement: 1.6 mcg/kg/day based on ideal body weight 1, 2
- Most women require 75-100 mcg/day; most men require 100-150 mcg/day 3
- Full replacement leads to more rapid TSH normalization without affecting symptom resolution time 1
- Use ideal body weight for calculations, as lean body mass best predicts requirements 1
Elderly Patients (>50-60 years)
- Start with 50 mcg daily for those without coronary heart disease 1, 2
- Elderly patients require 20-25% less per kilogram than younger patients due to decreased lean body mass 1
- Recent evidence suggests elderly patients need approximately 1.09 mcg/kg actual body weight or 1.35 mcg/kg ideal body weight - one-third lower than younger populations 4
- For those with known coronary disease, reduce starting dose to 12.5-25 mcg/day 1
Subclinical Hypothyroidism
- Initial dose: 25-75 mcg daily depending on TSH elevation 1
- A practical approach based on TSH levels 1:
- TSH 4.0-8.0 mIU/L: Start 25 mcg
- TSH 8-12 mIU/L: Start 50 mcg
- TSH >12 mIU/L: Start 75 mcg
- After 2 months, minimal adjustments typically needed 1
Pediatric Patients
Dosing is weight-based and age-dependent 2:
- 0-3 months: 10-15 mcg/kg/day
- 3-6 months: 8-10 mcg/kg/day
- 6-12 months: 6-8 mcg/kg/day
- 1-5 years: 5-6 mcg/kg/day
- 6-12 years: 4-5 mcg/kg/day
- >12 years (growth incomplete): 2-3 mcg/kg/day
- Growth complete: 1.6 mcg/kg/day
Critical caveat: Infants 0-3 months at risk for cardiac failure require lower starting doses with increases every 4-6 weeks 2
Pregnant Patients
- Pre-existing hypothyroidism: Increase pre-pregnancy dose by 12.5-25 mcg as soon as pregnancy confirmed 2
- Target TSH goals 1:
- First trimester: <2.5 mIU/L
- Second trimester: <3.0 mIU/L
- Third trimester: <3.5 mIU/L
- Monitor TSH every 4 weeks during first half of pregnancy, then once between 26-32 weeks 1
Dose Adjustment and Monitoring
Titration Schedule
- Check TSH 4-8 weeks after initiation or dose changes 1
- Adjust by 12.5-25 mcg increments every 4-6 weeks for adults 2
- For elderly or cardiac patients, titrate every 6-8 weeks 2
- Pediatric patients: titrate every 2 weeks 2
- Peak therapeutic effect may not occur for 4-6 weeks 2
Maintenance Monitoring
- Once euthyroid, check TSH annually if stable 5
- For elderly patients, target TSH within age-adjusted normal range (e.g., upper limit 7 mIU/L for ages 70-79,8 mIU/L for >80 years) 5
- Avoid TSH <1 mIU/L to prevent thyrotoxicosis risk 5
Special Dosing Considerations
Obesity: For obese patients, calculate dose using ideal body weight rather than actual body weight to avoid overdosing 1, 4
Post-thyroidectomy: Athyreotic patients may require higher doses, approximately 1.5 mcg/kg after total thyroidectomy 1, 6
Central hypothyroidism: May require higher doses than primary hypothyroidism; monitor using free T4 (not TSH) targeting upper half of normal range 1, 2
Adrenal insufficiency: Must treat with hydrocortisone before initiating levothyroxine to avoid precipitating adrenal crisis 1
Administration Guidelines
Timing: Take with water 30-60 minutes before breakfast OR at bedtime 4 hours after last meal 1
Recent evidence suggests a 15% dose increase allows for non-fasting breakfast administration while maintaining TSH stability, which significantly improves patient adherence and well-being 7
Drug interactions: Administer at least 4 hours before or after medications that interfere with absorption 2. When such medications are started or stopped, recheck TSH within 4-8 weeks 1
Pediatric administration: For children unable to swallow tablets, crush and suspend in 5-10 mL water; administer immediately 2
Red Flags Requiring Dose Adjustment
- Doses >200 mcg/day rarely needed; >300 mcg/day suggests non-compliance, malabsorption, or drug interactions 2
- Persistently elevated TSH on high doses warrants evaluation for compliance issues (most common) or absorption problems 1
- Weekly dosing may be considered for patients with significant compliance problems 1
- Monitor for cardiac symptoms (angina) when treating elderly or cardiac patients - may limit ability to achieve full euthyroidism 1